Tomoharu Tokutomi

Prof. Dr. Tomoharu Tokutomi

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2022 in The Journal of Pediatrics
Verified
Journal Article
Open access
HSHisato Suzuki
Hisato Suzuki
MNMasatoshi Nozaki
Masatoshi Nozaki
HYHiroshi Yoshihashi
Hiroshi Yoshihashi
KIKazuo Imagawa
Kazuo Imagawa
DKDaigo Kajikawa
Daigo Kajikawa
TTToshiki Takenouchi
Toshiki Takenouchi
To delineate the diagnostic efficacy of medical exome, whole exome, and whole genome sequencing according to primary symptoms, the contribution of small copy number variations, and the impact of molecular diagnosis on clinical management. This was a prospective study of 17 tertiary care centers in Japan, conducted between April 2019 and March 2021. Critically ill neonates and infants less than 6 months of age were recruited in neonatal intensive care units and in outpatient clinics. The patients underwent medical exome, whole exome, or whole genome sequencing as the first tier of testing. Patients with negative results after medical exome or whole exome sequencing subsequently underwent whole genome sequencing. The impact of molecular diagnosis on clinical management was evaluated through contacting primary care physicians. Of the 85 patients, 41 (48%) had positive results. Based on the primary symptoms, patients with metabolic phenotypes had the highest diagnostic yield (67%, 4/6 patients), followed by renal (60%, 3/5 patients), and neurologic phenotypes (58%, 14/24 patients). Among them, 4 patients had pathogenic small copy number variations identified using whole genome sequencing. In the 41 patients with a molecular diagnosis, 20 (49%) had changes in clinical management. Genome analysis for critically ill neonates and infants had a high diagnostic yield for metabolic, renal, and neurologic phenotypes. Small copy number variations detected using whole genome sequencing contributed to the overall molecular diagnosis in 5% of all the patients. The resulting molecular diagnoses had a significant impact on clinical management.

8 July 2021 in Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
HKHiroshi Kawame
Hiroshi Kawame
AFAkimune Fukushima
Akimune Fukushima
NFNobuo Fuse
Nobuo Fuse
FNFuji Nagami
Fuji Nagami
YSYoichi Suzuki
Yoichi Suzuki
MYMasayuki Yamamoto
Masayuki Yamamoto

14 July 2017 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
Tomoharu TokutomiTomoharu Tokutomi
Tomoharu Tokutomi
AFAkimune Fukushima
Akimune Fukushima
KYKayono Yamamoto
Kayono Yamamoto
YBYasushi Bansho
Yasushi Bansho
THTsuyoshi Hachiya
Tsuyoshi Hachiya
ASAtsushi Shimizu
Atsushi Shimizu
The Tohoku Medical Megabank project aims to create a next-generation personalized healthcare system by conducting large-scale genome-cohort studies involving three generations of local residents in the areas affected by the Great East Japan Earthquake. We collected medical and genomic information for developing a biobank to be used for this healthcare system. We designed a questionnaire-based pedigree-creation software program named “f-treeGC,” which enables even less experienced medical practitioners to accurately and rapidly collect family health history and create pedigree charts. f-treeGC may be run on Adobe AIR. Pedigree charts are created in the following manner: 1) At system startup, the client is prompted to provide required information on the presence or absence of children; f-treeGC is capable of creating a pedigree up to three generations. 2) An interviewer fills out a multiple-choice questionnaire on genealogical information. 3) The information requested includes name, age, gender, general status, infertility status, pregnancy status, fetal status, and physical features or health conditions of individuals over three generations. In addition, information regarding the client and the proband, and birth order information, including multiple gestation, custody, multiple individuals, donor or surrogate, adoption, and consanguinity may be included. 4) f-treeGC shows only marriages between first cousins via the overlay function. 5) f-treeGC automatically creates a pedigree chart, and the chart-creation process is visible for inspection on the screen in real time. 6) The genealogical data may be saved as a file in the original format. The created/modified date and time may be changed as required, and the file may be password-protected and/or saved in read-only format. To enable sorting or searching from the database, the file name automatically contains the terms typed into the entry fields, including physical features or health conditions, by default. 7) Alternatively, family histories are collected using a completed foldable interview paper sheet named “f-sheet”, which is identical to the questionnaire in f-treeGC. We developed a questionnaire-based family tree-creation software, named f-treeGC, which is fully compliant with international recommendations for standardized human pedigree nomenclature. The present software simplifies the process of collecting family histories and pedigrees, and has a variety of uses, from genome cohort studies or primary care to genetic counseling.

28 March 2023 in Genes
Verified
Journal Article
Open access
PDF file
AYAkiko Yoshida
Akiko Yoshida
Tomoharu TokutomiTomoharu Tokutomi
Tomoharu Tokutomi
AFAkimune Fukushima
Akimune Fukushima
RCRobert Chapman
Robert Chapman
Fatos SelitaFatos Selita
Fatos Selita
MSMakoto Sasaki
Makoto Sasaki
Knowledge of genetics is essential for understanding the results of genetic testing and its implications. Recent advances in genomic research have allowed us to predict the risk of onset of common diseases based on individual genomic information. It is anticipated that more people will receive such estimates of risks based on their genomic data. However, currently, there is no measure for genetic knowledge that includes post-genome sequencing advancements in Japan. In this study, we translated the genomic knowledge measure in the International Genetics Literacy and Attitudes Survey (iGLAS-GK) into Japanese and validated it in a general Japanese adult population (n = 463). The mean score was 8.41 (SD 2.56, range 3–17). The skewness and kurtosis were 0.534 and 0.088, respectively, and the distribution showed a slightly positive skewness. Exploratory factor analysis proposed a six-factor model. Results for 16 of the 20 items of the Japanese version of the iGLAS-GK were comparable to those from previous studies in other populations. These results indicate that the Japanese version is reliable and can be used to measure the genomic knowledge of adults in the general population, and this version of the knowledge measure maintains the multidimensional structure for assessing genomic knowledge.

18 April 2023 in Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
TSTomohiro Sakaguchi
Tomohiro Sakaguchi
Tomoharu TokutomiTomoharu Tokutomi
Tomoharu Tokutomi
AYAkiko Yoshida
Akiko Yoshida
KYKayono Yamamoto
Kayono Yamamoto
KOKeiko Obata
Keiko Obata
AFAkimune Fukushima
Akimune Fukushima

21 March 2024 in Genes
Verified
Journal Article
Open access
PDF file
Tomoharu TokutomiTomoharu Tokutomi
Tomoharu Tokutomi
AYAkiko Yoshida
Akiko Yoshida
AFAkimune Fukushima
Akimune Fukushima
KYKayono Yamamoto
Kayono Yamamoto
IYISHIGAKI YASUSHI
ISHIGAKI YASUSHI
MSMakoto Sasaki
Makoto Sasaki
Genetic testing is key in modern healthcare, particularly for monogenic disorders such as familial hypercholesterolemia. This Tohoku Medical Megabank Project study explored the impact of first-degree relatives’ dyslipidemia history on individual responses to familial hypercholesterolemia genomic results. Involving 214 participants and using Japan’s 3.5KJPN genome reference panel, the study assessed preferences and intentions regarding familial hypercholesterolemia genetic testing results. The data revealed a significant inclination among participants with a family history of dyslipidemia to share their genetic test results, with more than 80% of participants intending to share positive results with their partners and children and 98.1% acknowledging the usefulness of positive results for personal health management. The study underscores the importance of family health history in genetic-testing perceptions, highlighting the need for family-centered approaches in genetic counseling and healthcare. Notable study limitations include the regional scope and reliance on questionnaire data. The study results emphasize the association between family health history and genetic-testing attitudes and decisions.